Tetra Radar · FDA Approvals · Decision date
Quimilza: FDA decision date
Anaptysbio, Inc (ANAB) · 12 December 2026
FDA target action date (PDUFA) of December 12, 2026, for Quimilza in generalized pustular psoriasis (GPP).
Source: 8-K of 12 November 2026
The decision is pending.
A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.